109 related articles for article (PubMed ID: 7370919)
1. Histologic features of tumors and the female superiority in survival from malignant melanoma.
Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
Cancer; 1980 Apr; 45(7):1604-8. PubMed ID: 7370919
[TBL] [Abstract][Full Text] [Related]
2. The female superiority in survival in clinical stage II cutaneous malignant melanoma.
Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
Cancer; 1982 May; 49(9):1941-4. PubMed ID: 7074591
[TBL] [Abstract][Full Text] [Related]
3. Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival.
Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
Cancer; 1980 Dec; 46(12):2731-5. PubMed ID: 7448711
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the histological features of malignant melanoma.
McGovern VJ; Shaw HM; Milton GW; Farago GA
Histopathology; 1979 Sep; 3(5):385-93. PubMed ID: 488922
[TBL] [Abstract][Full Text] [Related]
5. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of a polypoid configuration in malignant melanoma.
McGovern VJ; Shaw HM; Milton GW
Histopathology; 1983 Sep; 7(5):663-72. PubMed ID: 6629342
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
[TBL] [Abstract][Full Text] [Related]
8. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma.
Kuehnl-Petzoldt C; Keil H; Schoepf E
Arch Dermatol Res; 1984; 276(3):151-5. PubMed ID: 6476888
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
12. Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator.
Kelly JW; Sagebiel RW; Clyman S; Blois MS
Ann Surg; 1985 Jul; 202(1):98-103. PubMed ID: 4015217
[TBL] [Abstract][Full Text] [Related]
13. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
Cox NH; Aitchison TC; Sirel JM; MacKie RM
Br J Cancer; 1996 Apr; 73(7):940-4. PubMed ID: 8611411
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
15. Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status.
MacKie RM; Hole DJ
BMJ; 1996 May; 312(7039):1125-8. PubMed ID: 8620127
[TBL] [Abstract][Full Text] [Related]
16. Tumor thickness and prognosis in clinical stage I malignant melanoma.
Karakousis CP; Emrich LJ; Rao U
Cancer; 1989 Oct; 64(7):1432-6. PubMed ID: 2776106
[TBL] [Abstract][Full Text] [Related]
17. Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981.
Heenan PJ; English DR; Holman CD; Armstrong BK
Cancer; 1991 Nov; 68(9):2079-87. PubMed ID: 1913557
[TBL] [Abstract][Full Text] [Related]
18. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.
Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A
Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942
[TBL] [Abstract][Full Text] [Related]
19. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
Barnhill RL; Fine JA; Roush GC; Berwick M
Cancer; 1996 Aug; 78(3):427-32. PubMed ID: 8697387
[TBL] [Abstract][Full Text] [Related]
20. Volume of malignant melanoma is superior to thickness as a prognostic indicator. Preliminary observation.
Friedman RJ; Rigel DS; Kopf AW; Grin CM; Heilman E; Bart RS; Kamino H; Harris MN; Roses DF; Postel AH
Dermatol Clin; 1991 Oct; 9(4):643-8. PubMed ID: 1934639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
